According to a report published by Report Buyer, the global stroke diagnostics & therapeutics market is estimated to grow at a CAGR of 6.68% over 2014-2022 to reach USD 34.4 billion in 2022. The market reported USD 20.5 billion revenue in 2014. The factors driving the growth of the market include availability of innovative products based on advanced technologies, rising elderly population, rising number of people suffering from diabetes, increasing health disbursement, hypertension and rising number of tobacco users. However, complicated reimbursement policies and high cost of treatments may impact the market growth negatively. Presently, North America is leading the stroke diagnostics & therapeutics market followed by Europe. Asia would be the hot destination for the growth of the stroke diagnostics and therapeutics market in the near future due to growing elderly population, rising R&D activities, governmental support, growing cognizance level about stroke and its causes, and developing healthcare framework in the region. Abbott Laboratories, Siemens, Stryker, GE Healthcare, Medtronic, Cordis Corporation, Genentech, Boston Scientific, Coaxia and Philips Healthcare are some of the major players of global stroke diagnostics and therapeutics market.
